Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2014

Dec 19, 2014

29777_dirs_2014-12-19_81cbce71-2217-48fc-b1cf-ca8ef9013467.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2014-12-12

Reporting Person: WHITE MILES D (Director, Chairman and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-12-12 Common shares without par value G 1440 Disposed 1413085 Direct
2014-12-12 Common shares without par value G 295 Acquired 8158 Indirect
2014-12-12 Common shares without par value G 295 Acquired 8067 Indirect
2014-12-12 Common shares without par value G 555 Acquired 555 Indirect
2014-12-12 Common shares without par value G 555 Disposed 0 Indirect
2014-12-12 Common shares without par value G 185 Acquired 8343 Indirect
2014-12-12 Common shares without par value G 185 Acquired 8252 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 26973 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 18, 2014.

F2: The reporting person disclaims beneficial ownership of all securities held by his wife and sons.